Healthequity Inc ( (HQY) ) has released its Q3 earnings. Here is a breakdown of the information Healthequity Inc presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HealthEquity Inc., a prominent player in the healthcare financial services sector, specializes in administering health savings accounts (HSAs) and consumer-directed benefits (CDBs), aiming to empower healthcare consumers through tax-advantaged savings solutions.
In its latest earnings report for the third quarter ending October 31, 2025, HealthEquity Inc. showcased a robust financial performance with a 7% increase in revenue, reaching $322.2 million. The company also reported a significant rise in net income per diluted share, climbing to $0.59 from $0.06 in the previous year, alongside a 29% increase in non-GAAP net income per diluted share to $1.01.
Key financial highlights include a 15% growth in total HSA assets to $34.4 billion and a notable return of $93.7 million to shareholders through stock repurchases. The company also successfully reduced its HSA cash repricing risk with a substantial Treasury bond hedge. HealthEquity’s Adjusted EBITDA grew by 20% to $141.8 million, representing 44% of revenue, up from 39% the previous year.
Looking forward, HealthEquity’s management anticipates continued growth, projecting annual revenues between $1.302 billion and $1.312 billion for the fiscal year ending January 31, 2026. The company remains focused on expanding its marketplace platform and leveraging AI to enhance personalized healthcare experiences, maintaining its mission to improve lives by empowering healthcare consumers.